XML 52 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1

Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The Company’s revenue by product line, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:

			Twelve Months Ended December 31, 2024 and 2023
			2024												2023												2022
Nylon			$	348,501					23%						$	356,632					23%						$	485,241					25%
Caprolactam			276,303						18%						298,375						20%						319,863						16%
Plant Nutrients*			458,152						30%						477,929						31%						657,984						34%
Chemical Intermediates*			434,601						29%						400,663						26%						482,552						25%
			$	1,517,557					100%						$	1,533,599					100%						$	1,945,640					100%

* The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

The Company’s revenues by geographic area, and related approximate percentage of total sales for 2024, 2023 and 2022 were as follows:

			Twelve Months Ended December 31, 2024 and 2023
			2024												2023												2022
United States			$	1,304,971					86		%				$	1,250,094					82		%				$	1,622,537					83		%
International			212,586						14		%				283,505						18		%				323,103						17		%
Total			$	1,517,557					100		%				$	1,533,599					100		%				$	1,945,640					100		%

Schedule of Deferred Income and Customer Advances

Below is a roll-forward of Deferred income and customer advances for the twelve months ended December 31, 2024:

Deferred Income and Customer Advances									2024
Opening balance January 1, 2024									$	15,678
Additional cash advances									37,954
Less amounts recognized in revenues									(16,094)
Ending balance December 31, 2024									$	37,538

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration